Free Trial

Rapport Therapeutics (RAPP) Insider Trading & Ownership

Rapport Therapeutics logo
$18.07 +0.21 (+1.18%)
(As of 12/20/2024 05:16 PM ET)

Rapport Therapeutics (NASDAQ:RAPP) Insider Buying and Selling Activity

Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$1.08 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get RAPP Insider Trade Alerts

Want to know when executives and insiders are buying or selling Rapport Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RAPP Insider Buying and Selling by Quarter

Rapport Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/1/2024James HealyDirectorBuy44,032$24.52$1,079,664.64  
(Data available from 1/1/2013 forward)

RAPP Insider Trading Activity - Frequently Asked Questions

The list of insiders at Rapport Therapeutics includes James Healy. Learn more on insiders at RAPP.

The following insider purchased RAPP shares in the last 24 months: James Healy ($1,079,664.64).

Insiders have purchased a total of 44,032 RAPP shares in the last 24 months for a total of $1,079,664.64 bought.



This page (NASDAQ:RAPP) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners